Hickey David has filed 7 insider transactions across 1 company since August 2023.
Most recent transaction: a grant/award of 1663 shares of BECTON DICKINSON & CO ($BDX) on November 26, 2023.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 26, 2023 | BECTON DICKINSON & CO | $BDX | Hickey David | EVP & President, Life Sciences | A | Common Stock | 1663 | $0.00 | 5,862.0000 | 288,392,000 | 39.60% | 0.00% |
| Nov. 26, 2023 | BECTON DICKINSON & CO | $BDX | Hickey David | EVP & President, Life Sciences | A | Stock Appreciation Rights | 9213 | $0.00 | 9,213.0000 | 288,392,000 | 9999.99% | 0.00% |
| Nov. 26, 2023 | BECTON DICKINSON & CO | $BDX | Hickey David | EVP & President, Life Sciences | A | Rights to Common Stock Under Deferred Compensation Plan | 3024 | $0.00 | 12,237.0000 | 288,392,000 | 32.82% | 0.00% |
| Aug. 11, 2023 | BECTON DICKINSON & CO | $BDX | Hickey David | EVP & President, Life Sciences | M | Common Stock | 3883 | $132.54 | 9,030.0000 | 0 | 75.44% | 0.00% |
| Aug. 11, 2023 | BECTON DICKINSON & CO | $BDX | Hickey David | EVP & President, Life Sciences | D | Common Stock | 1857 | $277.85 | 7,173.0000 | 0 | 20.56% | 0.00% |
| Aug. 11, 2023 | BECTON DICKINSON & CO | $BDX | Hickey David | EVP & President, Life Sciences | S | Common Stock | 2974 | $277.85 | 4,199.0000 | 0 | 41.46% | 0.00% |
| Aug. 11, 2023 | BECTON DICKINSON & CO | $BDX | Hickey David | EVP & President, Life Sciences | M | Stock Appreciation Rights | 3883 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |